SynthesisInternational journal of clinical oncology2018

Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial.

Jianhong Zhu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.